Biocryst Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Biocryst Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Biocryst Pharmaceuticals Inc.
Rating: 1.33191675
Author: Trendlyne DVM scores

about

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...

8.34 -0.13 (-1.53%)

26.26% Fall from 52W High

682.9K

XNAS Volume

XNAS 29 Aug, 2025 11:48 AM (EDT)

Board Meeting

The next board meeting for Biocryst Pharmaceuticals Inc. is on 04 Sep 2025 for the purpose of Cantor Global Healthcare Conference See details

Not Eligible

Expensive Valuation

11.7 / 100

Technically Neutral

41.6 / 100

1Yr Price target upside is 101%

11 analysts

Biocryst Pharmaceuticals Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Biocryst Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...

26.26% Fall from 52W High

SWOT Analysis

Biocryst Pharmaceuticals Inc. Live Price Chart